* OrthoPediatrics Corp KIDS.OQ KIDS.O is expected
to show a
rise in quarterly revenue when it reports results on August 5
for the period ending June 30 2024
* The Warsaw Indiana Indiana-based company is expected to
report
a 32.7% increase in revenue to $52.495 million from $39.56
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
* LSEG's mean analyst estimate for OrthoPediatrics Corp is
for a
loss of 27 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
OrthoPediatrics
Corp is $43.00, above its last closing price of $29.56.
This summary was machine generated August 3 at 01:47 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)